Altered expression of fatty acid-metabolizing enzymes in aromatase- deficient mice

Journal of Clinical Investigation

Volumn 105, Issue 12, 2000, Pages 1819-1825

  Nemoto, Yoshihisa ^a   Toda, Katsumi ^a   Ono, Masafumi ^a   Fujikawa Adachi, Kiyomi ^a   Saibara, Toshiji ^a   Onishi, Saburo ^a   Enzan, Hideaki ^a   Okada, Teruhiko ^a   Shizuta, Yutaka ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; AROMATASE; ESTRADIOL; ESTROGEN; LONG CHAIN FATTY ACID COENZYME A LIGASE;

ARTICLE; DISEASE ASSOCIATION; ENZYME ACTIVITY; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY LIVER; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033917322     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI9575     Document Type: Article

References (33)

1. Sherlock, S., and Dooley, J. 1997. Alcohol and the liver. In Diseases of the liver and biliary system. 10th edition. S. Sherlock and J. Dooley, editors. Blackwell Science Ltd. Oxford, United Kingdom, 385-404.
2. James, O., and Day, C. 1999. Non-alcoholic steatohepatitis: another disease of affluence. Lancet. 353:1634-1636.
3. Berson, A., et al. 1998. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology, 114:764-774.
4. Ludwig, J., Viggiano, T.R., McGill, D.B., and Ott, B. 1980 Nonalcoholic steatohepatitis; Mayo clinic experiences with a hitherto unnamed disease. Mayo Clin. Proc. 55:434-438.
5. Kato, K., et al. 1980. Evaluation of computed tomography in the diagnosis of liver diseases. Liver. 21:1340-1351.
6. Day, C.P., and James, O.F. 1998. Hepatic steatosis: innocent bystander or guilty party? Hepatology. 27:1463-1466.
7. Wanless, I.R., and Lentz, J.S. 1990. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 12:1106-1110.
8. Oien, K.A., et al. 1999. Cirrhosis with steatohepatitis after adjuvant tamoxifen. Lancet. 353:36-37.
9. Yang, S.Q., Lin, H.Z., Lane, M.D., Clemens, M., and Diehl, A.M. 1997. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc. Natl. Acad. Sci. USA. 94:2557-2562.
10. Day, C.P., and James, O.F.W. 1998 Steatohepatitis: a tale of two "hits"? Gastroenterology. 114:842-845.
11. Wilcken, N.R. 1999. Tamoxifen hits the target in situ. Lancet 353:1986-1987.
12. Fisher, B., et al. 1998. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer. Inst. 90:1371-1388.
13. Fisher, B., et al. 1999. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet. 353:1993-2000.
14. Pratt, D.S., Knox, T.A., and Erban, J. 1995. Tamoxifen-induced steatohepatitis. Ann. Intern. Med. 123:236.
15. Pinto, H.C., et al. 1995. Tamoxifen-associated steatohepatitis: report of three cases. J. Hepatol. 23:95-97.
16. Van Hoof, M., Rahier, J., and Horsmans, Y. 1996. Tamoxifen-induced steatohepatitis. Ann. Intern. Med. 124:855-856.
17. Ogawa, Y., Murata, Y., Nishioka, A., Inomata, T., and Yoshida, S. 1998. Tamoxifen-induced fatty liver in patients with breast cancer. Lancet. 351:725.
18. Saibara, T., Onishi, S., Ogawa, Y., Yoshida, S., and Enzan, H. 1999. Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis. Lancet. 353:1802.
19. Saibara, T., Onishi, S., Ogawa, Y., Yoshida, S., and Enzan, H. 1999. Non-alcoholic steatohepatitis. Lancet. 354:1299-1300.
20. Djouadi, F., et al. 1998. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor a-deficient mice. J. Clin. Invest. 102:1083-1091.
21. Akhtar, M., Calder, M.R., Corina, D.L., and Wright, J.N. 1982. Mechanistic studies on C-19 demethylation in oestrogen biosynthesis. Biochem. J. 201:569-580.
22. Fishman, J., and Goto, J. 1981. Mechanism of estrogen biosynthesis. Participation of multiple enzyme sites in placental aromatase hydroxylations. J. Biol. Chem. 256:4466-4471.
23. Toda, K., et al. 2000. Concentrations of monoamines and acetyl-choline in the brains of mice lacking the aromatase cytochrome P450 gene. In Molecular steroidgenesis. Frontiers Science Series No. 29. M. Okamoto, Y. Ishimura, and H. Newada, editors. University Academic Press Inc. Tokyo, Japan. 141-143.
24. Shindo, Y., Osumi, T., and Hashimoto, T. 1978. Effects of administration of di-(2-ethylhexyl) phthalate on rat liver mitochondria. Biochem. Pharmacol. 27:2683-2688.
25. Tsuji, S., et al. 1981. Abnormality of long-chain fatty acids in erythrocyte membrane sphingomyelin from patients with adrenoleukodystrophy. J. Neurochem. 36:1046-1049.
26. Jiang, S.W., and Eberhardt, N.L. 1995. A micro-scale method to isolate DNA-binding proteins suitable for quantitative comparison of expression levels from transfected cells. Nucleic Acid Res. 23:3607-3608.
27. Lowry, O.H., Rosenbrough, N.J., Farr, A.L., and Randall, R.J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
28. Osumi, T., Ishii, N., Miyazawa, S., and Hashimoto, T. 1987. Isolation and structural characterization of the rat acyl-CoA oxidase gene. J. Biol. Chem. 262:8138-8143.
29. Yeldandi, A.V., Rao, M.S., and Reddy, J.K. 2000. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Mutat. Res. 448:159-177.
30. Aoyama, T., et al. 1998. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα). J. Biol. Chem. 273:5678-5684.
31. Hashimoto, T. 1999. Peroxisomal beta-oxidation enzymes. Neurochem. Res. 24:551-563.
32. Ren, B., Thelen, A.P., Peters, J.M., Gonzalez, F.J., and Jump, D.B. 1997. Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require PPAR-alpha. J. Biol. Chem. 272:26827-26832.
33. Bocos, C.J.C., Moreno, E.S., Merritt, A., Cattley, R.C., and Gustafsson, J.A. 1997. Peroxisome proliferators alter the expression of estrogen-metabolizing enzymes. Biochemie. 79:151-162.